Business Context and Reporting Period
This Form 8-K is a current report filed by AcelRx Pharmaceuticals, Inc. (not TalpherA, Inc., as noted in the request metadata) on March 15, 2021. The filing serves to announce the company's financial results for the three and twelve months ended December 31, 2020. The company is incorporated in Delaware and trades on the Nasdaq Global Market under the symbol ACRX.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the provided source text. Consequently, no specific financial figures can be extracted from this document alone.
Material Changes
The filing does not detail specific material changes versus prior periods within the body text. It solely references the issuance of a press release containing the comparative financial results for the periods ended December 31, 2020.
Guidance, Outlook, and Risks
The document includes a standard legal disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is deemed "furnished" rather than "filed" under the Securities Exchange Act of 1934. As such, it is not subject to the liabilities of Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act of 1933, and will not be incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the Press Release dated March 15, 2021), as they are not present in the 8-K text.
- Confirm the company name is AcelRx Pharmaceuticals, Inc. (ACRX), noting the discrepancy with the "TALPHERA, INC." name in the request metadata.
- Review the full press release for any forward-looking statements or guidance that may have been issued alongside the financial results.
- Check subsequent filings (e.g., 10-K or 10-Q) for the audited or reviewed financial statements corresponding to the period ended December 31, 2020.